Condition
Immune-related Colitis
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Withdrawn2
Clinical Trials (2)
Showing 2 of 2 trials
NCT05726396Phase 2WithdrawnPrimary
A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis
NCT06646016Phase 2WithdrawnPrimary
EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis
Showing all 2 trials